LifeMD Inc (NASDAQ: LFMD) kicked off on Monday, up 8.55% from the previous trading day, before settling in for the closing price of $3.86. Over the past 52 weeks, LFMD has traded in a range of $3.18-$15.84.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -10.98%. While this was happening, its average annual earnings per share was recorded 60.38%. With a float of $39.43 million, this company’s outstanding shares have now reached $46.58 million.
LifeMD Inc (LFMD) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of LifeMD Inc is 18.09%, while institutional ownership is 42.88%. The most recent insider transaction that took place on Dec 09 ’25, was worth 54,158. In this transaction Chief Marketing Officer of this company sold 15,000 shares at a rate of $3.61, taking the stock ownership to the 205,000 shares. Before that another transaction happened on Nov 24 ’25, when Company’s Officer proposed sale 20,000 for $4.04, making the entire transaction worth $80,800.
LifeMD Inc (LFMD) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.21 earnings per share (EPS), higher than consensus estimate (set at 0.14) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 60.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 63.87% during the next five years compared to -10.98% drop over the previous five years of trading.
LifeMD Inc (NASDAQ: LFMD) Trading Performance Indicators
Take a look at LifeMD Inc’s (LFMD) current performance indicators. Last quarter, stock had a quick ratio of 0.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.80. Likewise, its price to free cash flow for the trailing twelve months is 18.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.17, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.33 in one year’s time.
